PHARMACOKINETICS OF CEFADROXIL AFTER ORAL-ADMINISTRATION IN HUMANS

被引：26

作者：

LAROSA, F ^{[1
]}

RIPA, S ^{[1
]}

PRENNA, M ^{[1
]}

GHEZZI, A ^{[1
]}

PFEFFER, M ^{[1
]}

机构：

[1] BRISTOL MYERS CO LABS,SYRACUSE,NY 13201

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1982年 / 21卷 / 02期

关键词：

D O I：

10.1128/AAC.21.2.320

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

页码：320 / 322

页数：3

共 8 条

[1]

ADAM D, 1980, INFECTION S5, V8, pS561

[2]

BUCK RD, 1976, ANTIMICROB AGENTS CH, V11, P324

[3]

Grove D.C., 1955, ASSAY METHODS ANTIBI

[4] PHARMACOKINETICS OF CEFADROXIL IN NORMAL SUBJECTS AND IN PATIENTS WITH RENAL-INSUFFICIENCY [J].

HUMBERT, G ;

LEROY, A ;

FILLASTRE, JP ;

GODIN, M .

CHEMOTHERAPY, 1979, 25 (04) :189-195

[5]

LODE H, 1980, ARZNEIMITTEL-FORSCH, V30-1, P505

[6] COMPARATIVE HUMAN ORAL CLINICAL PHARMACOLOGY OF CEFADROXIL, CEPHALEXIN, AND CEPHRADINE [J].

PFEFFER, M ;

JACKSON, A ;

XIMENES, J ;

PERCHEDEMENEZES, J .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1977, 11 (02) :331-338

[7] LABORATORY STUDIES WITH BL-S578 (CEFADROXIL) A NEW BROAD-SPECTRUM ORALLY ACTIVE CEPHALOSPORIN [J].

RIPA, S ;

PRENNA, M .

CHEMOTHERAPY, 1979, 25 (01) :9-13

[8]

SIMON C, 1980, ARZNEIMITTEL-FORSCH, V30-1, P502

← 1 →